Tuesday, September 1, 2015

Valeant Strikes Psoriasis-Drug Pact With AstraZeneca

Canada’s Valeant Pharmaceuticals has struck a deal with AstraZeneca of the U.K. to develop and sell psoriasis treatment brodalumab.

from WSJ.com: US Business http://ift.tt/1Jueah8
via IFTTT

No comments:

Post a Comment